Histological analysis verified that selenite and selenite + GMZ treatments decreased the expression of cell proliferation markers (i.e., Ki67) and that both treatments were able to inhibit MMP9, a protein closely related to the invasiveness of pancreatic cancer. The gene discussed is MMP9; the disease is pancreatic neoplasm.